Related references
Note: Only part of the references are listed.A transgenic mouse for in vivo detection of endogenous labeled mRNA
Timothee Lionnet et al.
NATURE METHODS (2011)
Most primary central nervous system diffuse large B-cell lymphomas occurring in immunocompetent individuals belong to the nongerminal center subtype: a retrospective analysis of 31 cases
Eyas M. Hattab et al.
MODERN PATHOLOGY (2010)
Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
Yung-Jue Bang et al.
LANCET (2010)
Immuno-Fluorescence In Situ Hybridization Index Predicts Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With R-CHOP: A GELA Study
Christiane Copie-Bergman et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Fluorescence and chromogenic in situ hybridization to detect genetic aberrations in formalin-fixed paraffin embedded material, including tissue microarrays
Brenda Summersgill et al.
NATURE PROTOCOLS (2008)
Close association between HER-2 amplification and overexpression in human tumors of non-breast origin
Coya Tapia et al.
MODERN PATHOLOGY (2007)
Base-stacking and base-pairing contributions into thermal stability of the DNA double helix
P Yakovchuk et al.
NUCLEIC ACIDS RESEARCH (2006)
In vivo biocompatibility and biodegradation of poly(ethylene carbonate)
M Dadsetan et al.
JOURNAL OF CONTROLLED RELEASE (2003)
Current perspectives on HER2 testing:: A review of national testing guidelines
M Bilous et al.
MODERN PATHOLOGY (2003)
Poly(ethylene carbonate)s, part II:: degradation mechanisms and parenteral delivery of bioactive agents
GH Stoll et al.
JOURNAL OF CONTROLLED RELEASE (2001)
Share Paper
